Clinical Trials List
2020-05-12 - 2025-12-31
Phase III
Not yet recruiting6
Recruiting2
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
Co-Principal Investigator
- Tzu-Tao Chen 未分科
- YEN-HAN TSENG 未分科
- Ching-Shan Luo Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
- Kuang-Tai Kuo Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yuh-Min Chen Division of Thoracic Medicine
- Heng-Sheng Chao 未分科
- Chi-Lu Chiang Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Han-Shui Hsu Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chien-Ying Liu Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- Chao Yin-Kai Division of Thoracic Surgery
- Chih-Hsi Kuo Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- Chih-Hung Chen 未分科
- Ping-Chih Hsu Division of Hematology & Oncology
- 吳青陽 Division of Thoracic Surgery
- Wen-Cheng Chang Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- Yi-Chen Wu Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chong-Jen Yu Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 廖唯昱 Division of General Internal Medicine
- JIN-SHING CHEN Division of General Surgery
- 陳克誠 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- SHUENN-WEN KUO Division of General Surgery
- YEN-TING LIN
- 徐偉勛 Division of General Surgery
- Hsao-Hsun Hsu Division of General Surgery
- 楊景堯 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- Mong-Wei Lin Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
32 participants
-
Global
332 participants
